ATRC.NASDAQAtricure, INC

Form 4: AtriCure CEO Gifts 4,000 Shares of Common Stock

Sentiment:

Insider Transaction Report


AtriCure's President and CEO, Michael H. Carrel, reported a charitable gift of 4,000 shares of the company's common stock.

Summary

  • Michael H. Carrel, President, CEO, and Director of AtriCure, Inc. (ATRC), reported a disposition of common stock.
  • On December 10, 2025, Mr. Carrel gifted 4,000 shares of AtriCure Common Stock.
  • No consideration was received in connection with this transaction, indicating a charitable gift.
  • Following the transaction, Mr. Carrel directly beneficially owns 687,377 shares of Common Stock.
  • He also indirectly beneficially owns 9,310 shares held by his children and 2,250 shares held by his parents, disclaiming beneficial ownership except for his pecuniary interest.

Sentiment

Score: 5

Explanation: The filing is a routine disclosure of an insider transaction (a charitable gift) and does not inherently convey positive or negative sentiment regarding the company's operational or financial performance.

Positives

  • The transaction represents a charitable contribution by the CEO.
  • The CEO retains a substantial direct beneficial ownership of 687,377 shares, indicating continued alignment with shareholder interests.

Negatives

  • A reduction of 4,000 shares in direct beneficial ownership by a key executive.

Risks

  • While a charitable gift is generally neutral, any reduction in insider ownership, even small, could be perceived by some as a minor decrease in management's direct stake in the company's future performance.

Future Outlook

N/A. This filing reports a past insider transaction and does not contain forward-looking statements or guidance.

Industry Context

N/A. This filing pertains to an individual insider transaction and does not provide information related to broader industry trends or competitive landscape.

Stakeholder Impact

  • Shareholders: Minimal impact. A slight reduction in direct insider ownership, but the CEO retains a significant stake.
  • Charitable Recipient: Benefits from the gift of 4,000 shares.

Key Dates

DateDescription
12/10/2025Date of transaction (charitable gift of common stock)
12/12/2025Date of filing signature

Keywords

AtriCure, ATRC, Michael H. Carrel, Insider Transaction, Form 4, Stock Gift, CEO, Beneficial Ownership, Common Stock

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.